Published on 14 Feb 2025 on Market Watch
Moderna looks to pipeline to restore battered stock after quarterly loss
COVID-19 vaccine sales topped consensus but RSV sales remain modest
NASDAQ.MRNA price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free